Safety and efficacy of Tirofiban in STEMI-patients-Reference-Cited by-同舟云学术

Safety and efficacy of Tirofiban in STEMI-patients

Published:2019-01 Issue: Volume:274 Page:35-39
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Dannenberg Lisa,Wolff Georg,Naguib David,Pöhl Martin,Zako Saif,Helten Carolin,Mourikis Philipp,Levkau Bodo,Hohlfeld Thomas,Zeus Tobias,Kelm Malte,Schulze Volker,Polzin Amin

Funder

Heinrich Heine University Düsseldorf

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Safety and efficacy of tirofiban as adjunctive therapy for patients with ST-elevation myocardial infarction: a comparison versus placebo and abciximab;Diaz;Cardiovasc. Hematol. Agents Med. Chem.,2011

2. ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation;Task Force on the management of STseami;Rev. Esp. Cardiol.,2009

3. Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty

4. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE trial;Valgimigli;J. Am. Coll. Cardiol.,2004

5. Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy;Smit;Heart,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemorrhagic complications of emergency endovascular interventions;Clinical Medicine (Russian Journal);2024-07-23

2. Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM;Rational Pharmacotherapy in Cardiology;2024-06-19

3. Electroacupuncture for slow flow/no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention: protocol for a pilot randomized controlled trial;Frontiers in Cardiovascular Medicine;2024-06-18

4. Biomedical and Biotechnological Potential of Animal Venoms: Bothrops Snake Venoms and their Antimicrobial Applications;Current Medicinal Chemistry;2024-04-26

5. The value of serum Sema4D level in predicting the prognosis of patients with acute ST-segment elevation myocardial infarction and with high thrombus burden;BMC Cardiovascular Disorders;2023-05-03